Wordt geladen...
Rivaroxaban versus Low-Molecular-Weight Heparin for Venous Thromboembolism in Gastrointestinal and Pancreatobiliary Cancer
BACKGROUND: Low-molecular-weight heparin (LMWH) is the standard treatment for venous thromboembolism (VTE) in patients with active cancer. However, use of factor Xa inhibitors, such as rivaroxaban, is increasing on the basis of limited clinical evidence. The present single-center study compared the...
Bewaard in:
| Gepubliceerd in: | J Korean Med Sci |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
The Korean Academy of Medical Sciences
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6543062/ https://ncbi.nlm.nih.gov/pubmed/31144482 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2019.34.e160 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|